Myriad Genetics Inc
NASDAQ:MYGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Myriad Genetics Inc
NASDAQ:MYGN
|
US |
|
Applovin Corp
NASDAQ:APP
|
US |
|
R
|
Radian Group Inc
XMUN:RAG
|
US |
|
Research Solutions Inc
NASDAQ:RSSS
|
US |
|
E
|
Exelon Corp
LSE:0IJN
|
US |
|
Hyatt Hotels Corp
NYSE:H
|
US |
|
CTS Corp
F:XT1
|
US |
|
W
|
Williams Companies Inc
XMUN:WMB
|
US |
|
N
|
NetApp Inc
DUS:NTA
|
US |
|
Farmland Partners Inc
NYSE:FPI
|
US |
|
E
|
electroCore, Inc.
F:43E
|
US |
|
Arvind Ltd
BSE:500101
|
IN |
|
B
|
Bank Handlowy w Warszawie SA
XMUN:6HW
|
PL |
Wall St Price Targets
MYGN Price Targets Summary
Myriad Genetics Inc
According to Wall Street analysts, the average 1-year price target for MYGN is 4.097 USD with a low forecast of 2.525 USD and a high forecast of 6.3 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MYGN's stock price target?
Price Target
4.097
USD
According to Wall Street analysts, the average 1-year price target for MYGN is 4.097 USD with a low forecast of 2.525 USD and a high forecast of 6.3 USD.
What is the Revenue forecast for Myriad Genetics Inc?
Projected CAGR
6%
Over the last 4 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 5 years is 6%.
What is the Gross Profit forecast for Myriad Genetics Inc?
Projected CAGR
8%
Over the last 4 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 4 years is 8%.
